BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551
208 results:

  • 1. A computer synoptic operative report versus a report dictated by a surgeon in advanced ovarian cancer.
    Bedel A; Blache G; Jauffret C; Houvenaeghel G; Buttarelli M; Sabiani L; Mokarram Dorri N; El Hajj H; Lambaudie E
    Int J Gynecol Cancer; 2024 Apr; 34(4):581-585. PubMed ID: 38336374
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Killing effect of anti-MSLN-iCAR-NK cells derived from induced pluripotent stem cells on ovarian epithelial cancer cells].
    Fan RJ; Zhang YF; Wang YY; Wang Y; Zheng W
    Zhonghua Fu Chan Ke Za Zhi; 2023 Dec; 58(12):922-929. PubMed ID: 38123198
    [No Abstract]    [Full Text] [Related]  

  • 3. Differential spatial distribution of HNF4α isoforms during dysplastic progression of intraductal papillary mucinous neoplasms of the pancreas.
    Wong J; Trinh VQ; Jyotsana N; Baig JF; Revetta F; Shi C; Means AL; DelGiorno KE; Tan M
    Sci Rep; 2023 Nov; 13(1):20088. PubMed ID: 37974020
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. RAD51D Secondary Mutation-Mediated Resistance to PARP-Inhibitor-Based Therapy in HGSOC.
    Xu J; Dai Y; Gao Y; Chai R; Lu C; Yu B; Kang Y; Xu C
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833926
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Transiently impaired endothelial function during thyroid hormone withdrawal in differentiated thyroid cancer patients.
    Hou LY; Li X; Zhang GQ; Xi C; Shen CT; Song HJ; Bai WK; Qiu ZL; Luo QY
    Front Endocrinol (Lausanne); 2023; 14():1164789. PubMed ID: 37424871
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Benign Paratesticular Fibrous Pseudotumor in a Young Male: A Case Report.
    Al-Shalah MI; Alabdallat S; Alzayed A; Abunaser N; Khamees A
    Urology; 2023 Jun; 176():171-174. PubMed ID: 36764489
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comprehensive characterization of complex glycosphingolipids in human pancreatic cancer tissues.
    Hořejší K; Jin C; Vaňková Z; Jirásko R; Strouhal O; Melichar B; Teneberg S; Holčapek M
    J Biol Chem; 2023 Mar; 299(3):102923. PubMed ID: 36681125
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Glutathione Transferase P1: Potential Therapeutic Target in Ovarian cancer.
    Simic P; Pljesa I; Nejkovic L; Jerotic D; Coric V; Stulic J; Kokosar N; Popov D; Savic-Radojevic A; Pazin V; Pljesa-Ercegovac M
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422199
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p/FOXP1 axis.
    Xia X; Li Z; Li Y; Ye F; Zhou X
    J Gynecol Oncol; 2022 Nov; 33(6):e81. PubMed ID: 36335987
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma - The Taiwan Cooperative Oncology Group T1217 study.
    Bai LY; Li CP; Shan YS; Chuang SC; Chen JS; Chiang NJ; Chen YY; Tsou HH; Chuang MH; Chiu CF; Liu TW; Chen LT
    Eur J Cancer; 2022 Sep; 173():123-132. PubMed ID: 35932625
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Wilms Tumor 1-Associated Protein Expression Is Linked to a T-Cell-Inflamed Phenotype in Pancreatic cancer.
    Xu JL
    Dig Dis Sci; 2023 Mar; 68(3):831-840. PubMed ID: 35859262
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic cancer.
    Schalck A; Sakellariou-Thompson D; Forget MA; Sei E; Hughes TG; Reuben A; Bai S; Hu M; Kumar T; Hurd MW; Katz MHG; Tzeng CD; Pant S; Javle M; Fogelman DR; Maitra A; Haymaker CL; Kim MP; Navin NE; Bernatchez C
    Cancer Discov; 2022 Oct; 12(10):2330-2349. PubMed ID: 35849783
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Acoustic triggered nanobomb for US imaging guided sonodynamic therapy and activating antitumor immunity.
    Li M; Zhu Y; Yang C; Yang M; Ran H; Zhu Y; Zhang W
    Drug Deliv; 2022 Dec; 29(1):2177-2189. PubMed ID: 35815688
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Retrospective Analysis of the Development of Human Thyroglobulin during Pregnancy in Patients with Treated Non-Recurrent Differentiated Thyroid cancer.
    Baumgarten J; Happel C; Groener D; Staudt J; Bockisch B; Sabet A; Grünwald F; Rink T
    Curr Oncol; 2022 May; 29(6):4012-4019. PubMed ID: 35735429
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes.
    Houvenaeghel G; de Nonneville A; Blache G; Buttarelli M; Jauffret C; Mokart D; Sabiani L
    J Gynecol Oncol; 2022 May; 33(3):e31. PubMed ID: 35320883
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Risk stratification of indeterminate thyroid nodules by novel multigene testing: a study of Asians with a high risk of malignancy.
    Hu C; Jing W; Chang Q; Zhang Z; Liu Z; Cao J; Zhao L; Sun Y; Wang C; Zhao H; Xiao T; Guo H
    Mol Oncol; 2022 Apr; 16(8):1680-1693. PubMed ID: 35247035
    [TBL] [Abstract] [Full Text] [Related]  

  • 17.
    Kraya AA; Maxwell KN; Eiva MA; Wubbenhorst B; Pluta J; Feldman M; Nayak A; Powell DJ; Domchek SM; Vonderheide RH; Nathanson KL
    JCO Precis Oncol; 2022 Feb; 6():e2100159. PubMed ID: 35201851
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Minimally invasive distal pancreatectomy: Chronologic changes in the trends and clinical outcomes through a 15-year, single-center experience with 2212 patients.
    Park Y; Hwang DW; Lee JH; Song KB; Jun E; Lee W; Hong S; Kim SC
    J Hepatobiliary Pancreat Sci; 2022 May; 29(5):540-551. PubMed ID: 35112510
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues.
    Yao T; Rudak PT; Laumont CM; Michaud AR; Rashu R; Knier NN; Foster PJ; McWilliam HEG; Villadangos JA; Nelson BH; DiMattia GE; Shepherd TG; Haeryfar SMM
    Cancer Immunol Immunother; 2022 May; 71(5):1259-1273. PubMed ID: 34854949
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial.
    Krug S; Kegel T; Gress TM; Rinke A; Apostolidis L; Jann H; König A; Hörsch D; Schrader J; Ettrich TJ; Richter M; Steighardt J; Michl P
    BMC Cancer; 2021 Nov; 21(1):1206. PubMed ID: 34772353
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.